Loading...

Human TruStain FcX™ (Fc Receptor Blocking Solution)

Pricing & Availability
Regulatory Status
RUO
Other Names
Fc Blocker, FcγR blocker, Fc inhibitor
Ave. Rating
Submit a Review
Product Citations
publications
A_Human_TruStain_FcX_031110
Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant rat IgG2b PE mAb (above). Dotted histogram represents unstained cells.
  • C_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (filled histograms) or non-treated (open histograms) THP-1 cells stained with anti-human HLA-DR PE (red) or an isotype control (IgG2a PE, blue) mAbs. Note: non-treated cells show false-negative HLA-DR staining due to high binding of mouse IgG2a isotype.
Cat # Size Price Save
422301 50 tests ¥22,220
422302 200 tests ¥50,380
Description

Human Fc receptors (FcRs) are expressed on a variety of cells, such as monocytes, granulocytes, B cells and dendritic cells. The cells with FcR expression sometimes give false positive or false negative results of immunofluorescent staining due to the FcRs-mediated Ig Fc binding. Human TruStain FcX™ is specially formulated for blocking the FcR-involved unwanted staining without interfering with antibody-mediated specific staining of human cells. Human TruStain FcX™ is compatible with flow cytometric staining with anti-human CD16 (clone 3G8), CD32 (clone FUN-2), and CD64 (clone 10.1) antibodies.

Product Details
Technical data sheet

Product Details

Storage & Handling
Store between 2°C and 8°C.
Application

FC - Quality tested
ICFC, ICC - Reported in the literature, not verified in house
Recommended Usage

It is recommended to add 5 µl of Human TruStain FcX™ per million cells in 100 µl staining volume, mix and incubate at room temperature for 5-10 minutes prior to staining with antibody of interest. It is not necessary to wash cells between these blocking and immunostaining steps.

Application Notes

This buffer contains specialized human IgG in PBS containing 0.09% sodium azide. It is not recommended to be used for staining human IgG. Handle as biohazard agent.

Application References

(PubMed link indicates BioLegend citation)
  1. de la Cruz J, et al. 2011. J. Immunol. 186:2282. PubMed
  2. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  3. Szerlip NJ, et al. 2012. PNAS. 109:3041. PubMed
  4. Bromley SK, et al. 2013. J. Immunol. 190:970. PubMed
  5. Trujilo G, et al. 2013. J. Immunol. 191:848. PubMed
  6. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  7. Euzebio Alves VT, et al. 2013. Infect Immun. 81:4399. PubMed
  8. Borg ZD, et al. 2014. J. Immunol. 192:189. PubMed
  9. Klingenberg R, et al. 2014. Eur Heart J. PubMed
  10. Lines JL, et al. 2014. Cancer Res. 74:1924. PubMed
  11. Decker D, et al. 2014. Lupus. 23:802. PubMed
  12. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  13. Anderson ME Jr, et al. 2014. Otolaryngol Head Neck Surg. 150:880. PubMed
  14. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  15. Shi J, et al. 2014. Blood. 123:4015. PubMed
  16. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  17. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  18. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  19. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  20. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  21. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  22. Vuong TT, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  23. Klingenberg R, et al. 2015. Eur Heart J. 36:1041. PubMed
  24. Wilkinson-Ryan I, et al. 2015. PLoS One.10:125851. PubMed
Product Citations
  1. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  2. Chen X, et al. 2019. Exp Ther Med. 1.265972222. PubMed
  3. Fisher RC, et al. 2019. Neoplasia. 1.061805556. PubMed
  4. Winkler CW, et al. 2019. J Neuroinflammation. 0.825694444. PubMed
  5. O'Huallachain M, et al. 2020. Commun Biol. 3:213. PubMed
  6. Klingenberg R, et al. 2014. Eur Heart J. . PubMed
  7. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  8. Simon A, et al. 2015. Blood. 126: 378 - 385. PubMed
  9. Mitton B, et al. 2016. Leukemia. 10.1038/leu.2016.139. PubMed
  10. Bera BS, et al. 2023. Epigenetics Chromatin. 16:14. PubMed
  11. Hu X, et al. 2023. Nat Biotechnol. . PubMed
  12. Luoma S, et al. 2023. Cancers (Basel). 15:. PubMed
  13. Lin W, et al. 2023. Commun Biol. 6:447. PubMed
  14. Wu C, et al. 2023. Cancer Metab. 11:7. PubMed
  15. Vokshi BH, et al. 2023. Nat Commun. 14:3034. PubMed
  16. Allard-Chamard H, et al. 2023. Cell Rep. 42:112630. PubMed
  17. Potts M, et al. 2023. Cell Rep. 42:112613. PubMed
  18. Diray-Arce J, et al. 2023. Cell Rep Med. 4:101079. PubMed
  19. Du J, et al. 2023. Nat Commun. 14:3675. PubMed
  20. Wanke F, et al. 2017. Cell Rep. 18(5):1270-1284. PubMed
  21. Ecker JW, et al. 2020. Vaccines (Basel). 8:00. PubMed
  22. Liu C, et al. 2021. Cell. 184(7):1836-1857.e22. PubMed
  23. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  24. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  25. Aguilar EG, et al. 2021. Blood Adv. 5:4219. PubMed
  26. Lambert E, et al. 2022. Acta Neuropathol Commun. 10:4. PubMed
  27. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  28. Ptacin JL, et al. 2021. Nat Commun. 12:4785. PubMed
  29. Lau D, et al. 2022. Nat Commun. 13:4053. PubMed
  30. Sipe CJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  31. Bahri R, et al. 2020. Methods Mol Biol. 2163:227. PubMed
  32. Liu T, et al. 2020. Biochem Biophys Res Commun. 532:385. PubMed
  33. McIlwain DR, et al. 2021. Cell Host Microbe. 29:1828. PubMed
  34. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  35. Chang M, et al. 2022. Biotechnol Bioeng. 119:1820. PubMed
  36. Ioannidis LJ, et al. 2022. STAR Protoc. 3:101269. PubMed
  37. Glass MC, et al. 2022. Cell Rep. 39:110728. PubMed
  38. Mair F, et al. 2022. Nature. 605:728. PubMed
  39. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  40. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  41. Jang HJ, et al. 2022. Cancer Res. 82:2593. PubMed
  42. Campisi L, et al. 2022. Nature. 606:945. PubMed
  43. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  44. Neely J, et al. 2022. Front Immunol. 13:902232. PubMed
  45. Feyaerts D, et al. 2022. Cell Rep Med. 3:100680. PubMed
  46. Werder RB, et al. 2022. Sci Adv. 8:eabo6566. PubMed
  47. Vazquez-Lombardi R, et al. 2022. Immunity. 55:1953. PubMed
  48. Calabrese DR, et al. 2022. JCI Insight. 7: . PubMed
  49. Scharf L, et al. 2023. JCI Insight. 8: . PubMed
  50. Messing M, et al. 2022. Front Immunol. 13:1010216. PubMed
  51. Wei H, et al. 2022. Front Immunol. 13:1060695. PubMed
  52. Wheeler MM, et al. 2022. Nat Commun. 13:7592. PubMed
  53. McEvoy CM, et al. 2022. Nat Commun. 13:7634. PubMed
  54. Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed
  55. Kim JR, et al. 2022. Cancer Immunol Immunother. :. PubMed
  56. Wu VH, et al. 2023. Nat Immunol. 24:359. PubMed
  57. Stuart T, et al. 2022. Nat Biotechnol. :. PubMed
  58. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  59. Chow A 2023. Immunity. 56(1):93-106.e6. PubMed
  60. Asashima H, et al. 2023. Cell Rep. 42:111895. PubMed
  61. Sun W, et al. 2023. Nature. 614:309. PubMed
  62. Miller RA, et al. 2022. J Immunother Cancer. 10: . PubMed
  63. Heinen N, et al. 2023. Front Immunol. 13:1062210. PubMed
  64. Rice CM, et al. 2023. Life Sci Alliance. 6: . PubMed
  65. De Bakshi D, et al. 2023. Life Sci Alliance. 6: . PubMed
  66. Liao J, et al. 2023. Nat Commun. 14:207. PubMed
  67. Li Z, et al. 2022. J Thorac Dis. 14:4815. PubMed
  68. Poon MML, et al. 2023. Nat Immunol. 24:309. PubMed
  69. Wang CQ, et al. 2023. Cells. 12: . PubMed
  70. Mohamed H, et al. 2023. Biomedicines. 11: . PubMed
  71. Ty M, et al. 2023. Sci Transl Med. 15:eadd9012. PubMed
  72. Sadashivaiah V, et al. 2023. BMC Neurosci. 24:6. PubMed
  73. Gilman KE, et al. 2023. Front Immunol. 13:1045710. PubMed
  74. He T, et al. 2023. Immun Inflamm Dis. 11:e759. PubMed
  75. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  76. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  77. Nandi I, et al. 2023. J Clin Invest. :. PubMed
  78. Chen SH, et al. 2022. Neurosci Bull. 38:290. PubMed
  79. Miller CL, et al. 2022. Cell Chem Biol. 29:451. PubMed
  80. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  81. Gomez-Salinero JM, et al. 2022. Cell Stem Cell. 29:593. PubMed
  82. Jaiswal A, et al. 2022. Cancer Cell. 40:524. PubMed
  83. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  84. Bednarski E, et al. 2022. MBio. 13:e0084022. PubMed
  85. Ferrall-Fairbanks MC, et al. 2022. Blood Cancer Discov. 3:536. PubMed
  86. Zhang X, et al. 2022. Cell Rep. 40:111363. PubMed
  87. Witkowski MT, et al. 2022. Nat Immunol. 23:1424. PubMed
  88. Gazinska P, et al. 2022. Clin Cancer Res. 28:4494. PubMed
  89. Li S, et al. 2022. Nature. 610:373. PubMed
  90. Xu Y, et al. 2022. Nat Genet. 54:1690. PubMed
  91. Ors A, et al. 2022. Nucleic Acids Res. 50:11492. PubMed
  92. Ainsua-Enrich E, et al. 2022. iScience. 25:105455. PubMed
  93. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  94. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  95. Bowley TY, et al. 2022. Cancer Res Commun. 2:1436. PubMed
  96. Imanishi M, et al. 2022. Front Cardiovasc Med. 9:988713. PubMed
  97. Ye D, et al. 2023. Cell Mol Neurobiol. 43:2337. PubMed
  98. Lai ZZ, et al. 2023. Front Immunol. 14:992765. PubMed
  99. Long D, et al. 2023. Eur J Immunol. 53:e2250109. PubMed
  100. Lareau CA, et al. 2023. Nat Protoc. 18:1416. PubMed
  101. Jun SH, et al. 2023. Nat Commun. 14:982. PubMed
  102. Ryan FJ, et al. 2023. Cell Rep Med. 4:100971. PubMed
  103. Lakkis J, et al. 2022. Nat Mach Intell. 4:940. PubMed
  104. Clark IC, et al. 2023. Nat Biotechnol. . PubMed
  105. Thaweerattanasinp T, et al. 2023. PeerJ. 11:e14918. PubMed
  106. Ishikawa M, et al. 2023. Front Immunol. 14:998233. PubMed
  107. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  108. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  109. Yao L, et al. 2022. Cancer Res Commun. 2:1255. PubMed
  110. Vasaikar SV, et al. 2023. Nat Commun. 14:1684. PubMed
  111. Persad S, et al. 2023. Nat Biotechnol. . PubMed
  112. Gao F, et al. 2023. Immunity. 56:864. PubMed
  113. Pinto C, et al. 2023. iScience. 26:106381. PubMed
  114. Im KW, et al. 2023. NPJ Breast Cancer. 9:22. PubMed
  115. Wu T, et al. 2023. Nat Methods. 20:723. PubMed
  116. Luo Y, et al. 2023. Cell Discov. 9:40. PubMed
  117. Jiang Y, et al. 2023. Sci Adv. 9:eadc8933. PubMed
  118. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  119. Woodley K, et al. 2023. Nat Commun. 14:2132. PubMed
  120. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  121. Thomas KA, et al. 2023. Transfusion. :S146. PubMed
  122. Boucher LE, et al. 2023. MAbs. 15:2195517. PubMed
  123. Lafôrets F, et al. 2023. iScience. 26:106514. PubMed
  124. Chen DY, et al. 2023. iScience. 26:106634. PubMed
  125. Solier S, et al. 2023. Nature. 617:386. PubMed
  126. Alber S, et al. 2022. Front Immunol. 13:838636. PubMed
  127. Jackson S, et al. 2016. J Exp Med. 213: 733 - 750. PubMed
  128. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  129. Vuong T, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  130. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  131. Starlard–Davenport A, et al. 2019. Br J Haematol. 186:91. PubMed
  132. Wartewig T, et al. 2017. Nature. . 10.1038/nature24649. PubMed
  133. Mehta P, et al. 2021. J Immunol. 207:1763. PubMed
  134. Lam B, et al. 2021. Cell Rep. 37:109838. PubMed
  135. de Cevins C, et al. 2021. Med (N Y). 2:1072. PubMed
  136. Gouin KH, et al. 2021. Nat Commun. 12:4906. PubMed
  137. Stanzione M, et al. 2022. Sci Adv. 8:eabn1229. PubMed
  138. Yoshida M, et al. 2022. Nature. 602:321. PubMed
  139. Egnuni T, et al. 2021. Pharmaceutics. 13:. PubMed
  140. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  141. Jundi B, et al. 2021. JCI Insight. 6:e148866. PubMed
  142. Friebel E, et al. 2020. Cell. 181(7):1626-1642.e20. PubMed
  143. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  144. Biasci D, et al. 2020. Proc Natl Acad Sci U S A. 117:28960. PubMed
  145. Glass DR, et al. 2020. Immunity. 53:217. PubMed
  146. Raju R, et al. 2017. Stem Cells Dev. 26:274. PubMed
  147. Karagiannis TT, et al. 2020. Nat Commun. 2.271527778. PubMed
  148. Trujillo G, et al. 2013. J Immunol. 191:848. PubMed
  149. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  150. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  151. Nielsen CM, et al. 2021. Cell Reports Medicine. 2(3):100207. PubMed
  152. Goveia J, et al. 2020. Cancer Cell. 21:37. PubMed
  153. Lee E, et al. 2021. Sci Rep. 11:14841. PubMed
  154. Doerflinger M, et al. 2021. Clin Transl Immunology. 10:e1235. PubMed
  155. Chen L, et al. 2021. Int J Mol Sci. 22:. PubMed
  156. Chen GM, et al. 2021. Cancer Discov. 11:2186. PubMed
  157. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  158. Rip J, et al. 2021. Bio Protoc. 11:e3902. PubMed
  159. Cluff E, et al. 2022. Cancer Immunol Immunother. . PubMed
  160. Mylka V, et al. 2022. Genome Biol. 23:55. PubMed
  161. Jairaman A, et al. 2022. Elife. 11:. PubMed
  162. Takano T, et al. 2022. Cell Rep Med. 3:100631. PubMed
  163. Vinjamur DS, et al. 2021. Nat Genet. 53:719. PubMed
  164. Judge SJ, et al. 2022. Front Immunol. 13:893177. PubMed
  165. Lo MW, et al. 2022. Clin Transl Immunology. 11:e1413. PubMed
  166. Masuda K, et al. 2022. JCI Insight. 7:. PubMed
  167. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  168. Lindgren I, et al. 2016. Hum Reprod. 31: 672 - 683. PubMed
  169. Beljanski V, et al. 2015. J Virol. 89: 10612 - 10624. PubMed
  170. Pontarini E, et al. 2015. Rheumatology. 54: 1429-1434. PubMed
  171. Feng WW, et al. 2019. Cell Rep. 29:3405. PubMed
  172. Li Z, et al. 2018. Exp Ther Med. 3.410416667. PubMed
  173. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  174. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  175. Zhou WH, et al. 2022. Discov Oncol. 13:67. PubMed
  176. Wang M, et al. 2022. Immun Inflamm Dis. 10:e626. PubMed
  177. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  178. Pérez-Pérez S, et al. 2022. Biomedicines. 10:. PubMed
  179. Figueroa-Romero C, et al. 2022. Front Immunol. 13:773288. PubMed
  180. Chen X, et al. 2022. Front Immunol. 12:807134. PubMed
  181. Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
  182. Snyder ME, et al. 2021. Am J Respir Crit Care Med. 203:1230. PubMed
  183. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  184. Gupta S, et al. 2020. Proc Natl Acad Sci U S A. 117:16481. PubMed
  185. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  186. Wright AKA, et al. 2017. J Allergy Clin Immunol. 140:1430. PubMed
  187. Al–Marsoummi S, et al. 2019. Cell Physiol Biochem. 53:999. PubMed
  188. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  189. Seamon K, et al. 2020. Front Immunol. 11:396. PubMed
  190. Jama B, Morris G 2014. J Vis Exp. 93: 52257. PubMed
  191. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  192. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  193. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  194. Wang E, et al. 2021. Cell Stem Cell. 28(4):718-731.e6. PubMed
  195. Harris MJ, et al. 2021. Mol Syst Biol. 17:e10091. PubMed
  196. Liu C, et al. 2021. Cell Res. 31:1106. PubMed
  197. Pickering H, et al. 2021. JCI Insight. 6:. PubMed
  198. Nugent JL, et al. 2021. iScience. 24:103421. PubMed
  199. Chen Z, et al. 2022. J Nanobiotechnology. 20:30. PubMed
  200. Ogbe A, et al. 2022. JCI Insight. . PubMed
  201. Sun V, et al. 2021. Front Immunol. 12:716661. PubMed
  202. Andrews JM, et al. 2021. EBioMedicine. 71:103559. PubMed
  203. Apostolidis SA, et al. 2022. Front Immunol. 13:834988. PubMed
  204. Woodruff MC, et al. 2022. Nature. :. PubMed
  205. Wang L, et al. 2022. Theranostics. 12:7216. PubMed
  206. Vir P, et al. 2015. PLoS One. 10: 0144904. PubMed
  207. Fuentes I, et al. 2020. Sci Rep. 10:15064. PubMed
  208. Stuart T, et al. 2019. Cell. 177:1888. PubMed
  209. Gao X, et al. 2017. PLoS One. 10.1371/journal.pone.0189167. PubMed
  210. Dashtsoodol N, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01206. PubMed
  211. Deng H, et al. 2017. Arthritis Res Ther. 10.1186/s13075-017-1339-4. PubMed
  212. Kumar V, et al. 2022. Cells. 11:. PubMed
  213. Burnett CE, et al. 2022. Immunity. 55:1284. PubMed
  214. Calianese D, et al. 2021. J Immunol. 207:436. PubMed
  215. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  216. Vijayakumar B, et al. 2022. Immunity. . PubMed
  217. Pérez-Pérez S, et al. 2021. Front Immunol. 12:798003. PubMed
  218. Chan JM, et al. 2021. Cancer Cell. 39:1479. PubMed
  219. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  220. Toulmin SA, et al. 2021. Nat Commun. 12:3993. PubMed
  221. Stephenson E, et al. 2021. Nat Med. 27:904. PubMed
  222. Layer JV, et al. 2020. Proc Natl Acad Sci U S A. 27566:117. PubMed
  223. Dogra P, et al. 2020. Cell. 749:180. PubMed
  224. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  225. Linke M, et al. 2017. Nat Immunol. 18:293-302. PubMed
  226. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  227. Zhang W, et al. 2019. Exp Ther Med. 2.490972222. PubMed
  228. Bocharnikov AV, et al. 2019. JCI Insight. 4:e126832. PubMed
  229. Mair F, et al. 2020. Cell Rep. 31:107499. PubMed
  230. Decker D, et al. 2014. Lupus. 123:2663. PubMed
  231. Lisovsky I, et al. 2015. J Virol. 89: 9909 - 9919. PubMed
  232. Busch S, et al. 2016. J Immunol. 197(11):4493-4503. PubMed
  233. Bowen J, et al. 2017. PLoS Pathog. 13(2):e1006164. PubMed
  234. Kreutmair S, et al. 2021. Immunity. . PubMed
  235. Rapiteanu R, et al. 2020. Eur Respir J. :55. PubMed
  236. Harrison TE, et al. 2020. Nature. 309:587. PubMed
  237. Poonpanichakul T, et al. 2021. Front Immunol. 12:599805. PubMed
  238. Sen K, et al. 2021. Front Immunol. 12:733539. PubMed
  239. Zheng S, et al. 2022. Blood Cancer Discov. 3:103. PubMed
  240. Quinn TM, et al. 2022. EBioMedicine. 76:103856. PubMed
  241. Vanshylla K, et al. 2022. Cell Host Microbe. 30:69. PubMed
  242. Worwa G, et al. 2022. Commun Biol. 5:1204. PubMed
  243. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  244. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  245. Abrecht C, et al. 2022. STAR Protoc. 3:101362. PubMed
  246. Lai ZZ, et al. 2020. Am J Reprod Immunol. 84:e13295. PubMed
  247. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  248. Romine KA, et al. 2021. Blood Cancer Discov. 2:518. PubMed
  249. Vanuytsel K, et al. 2022. Nat Commun. 13:1103. PubMed
  250. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  251. Muir LA, et al. 2022. JCI Insight. 7:. PubMed
  252. Romine KA, et al. 2021. Cancer Discov. . PubMed
  253. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  254. Shen Z, et al. 2021. iScience. 24:103014. PubMed
  255. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  256. Qiu XM, et al. 2020. Reproduction. 251:159. PubMed
  257. Gonzalez VD, et al. 2021. Cell Reports. 36(9):109632. PubMed
  258. Obradovic A, et al. 2021. Cell. 184(11):2988-3005.e16. PubMed
  259. Russ K, et al. 2021. Cell Reports. 34(12):108895. PubMed
  260. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  261. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  262. Market M, et al. 2020. Front Immunol. 1.127083333. PubMed
  263. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  264. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  265. Souriant S, et al. 2019. Cell Rep. 26:3586. PubMed
  266. Riordon DR, et al. 2017. Methods Mol Biol. 1722:127. PubMed
  267. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  268. Borg Z, et al. 2014. J Immunol. 192:189. PubMed
  269. Shi J, et al. 2014. Blood. 123:4015. PubMed
  270. Galvani S, et al. 2015. Sci Signal. 8: ra79. PubMed
  271. Boyerinas B, et al. 2015. Cancer Immunol Res. 3: 1148 - 1157. PubMed
  272. Zabransky DJ, et al. 2015. Proc Natl Acad Sci U S A. 112: 6205 -6214. PubMed
  273. Thorek D, et al. 2016. Sci Transl Med. 8: 367ra167. PubMed
  274. Le BV, et al. 2020. Cell Rep. 33:108221. PubMed
  275. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  276. Lu Q, et al. 2021. Immunity. 54(6):1304-1319.e9. PubMed
  277. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  278. Helmink BA, et al. 2020. Nature. 577:549. PubMed
  279. Cao Y, et al. 2021. Cell Res. 31:732. PubMed
  280. Wang W, et al. 2021. Clin Transl Med. 11:e253. PubMed
  281. Wang YC, et al. 2021. Nat Commun. 12:3530. PubMed
  282. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  283. Painter MM, et al. 2021. Immunity. 54:2133. PubMed
  284. Syrimi E, et al. 2021. iScience. 24:103215. PubMed
  285. Thijssen R, et al. 2022. Blood. :. PubMed
  286. Good Z, et al. 2022. Nat Med. :. PubMed
  287. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  288. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  289. Seifert L, et al. 2015. Cell Rep. 13: 1909-1921. PubMed
  290. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  291. Yoon J, et al. 2020. Front Cell Dev Biol. 0.520138889. PubMed
  292. Poon E, et al. 2017. J Immunother Cancer. 10.1186/s40425-017-0268-8. PubMed
  293. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  294. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  295. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  296. Jiang Y, et al. 2020. Br J Pharmacol. . PubMed
  297. Opzoomer JW, et al. 2021. Elife. :10. PubMed
  298. Woodruff M, et al. 2020. medRxiv. . PubMed
  299. Nabet BY, et al. 2020. Cell. 183(2):363-376.e13. PubMed
  300. Zobel MJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  301. Zhu Y, et al. 2019. Cell Stem Cell. 25:542. PubMed
  302. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  303. Lundholm M, et al. 2015. Sci Rep. 5: 15651. PubMed
  304. Revelo X, et al. 2016. Cell Rep. 16: 717-730. PubMed
  305. Thomas K, et al. 2016. J Leukoc Biol. 100: 177 - 184. PubMed
  306. Burns JC, et al. 2020. eLife. 9:00. PubMed
  307. Herati RS, et al. 2021. Cell Reports Medicine. 2(5):100262. PubMed
  308. Ziegler CGK, et al. 2021. Cell. 184(18):4713-4733.e22. PubMed
  309. An Y, et al. 2021. Sci Rep. 6392:11. PubMed
  310. Chen G, et al. 2021. Signal Transduct Target Ther. 6:289. PubMed
  311. Besnier M, et al. 2021. Antioxidants (Basel). 10:. PubMed
  312. Dugger DT, et al. 2021. Front Immunol. 12:704172. PubMed
  313. Vick SC, et al. 2021. Sci Adv. 7:eabj0274. PubMed
  314. Hu Y, et al. 2021. Am J Hum Genet. 108:874. PubMed
  315. Levi H, et al. 2022. J Exp Med. 219:. PubMed
  316. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  317. Trevelin SC, et al. 2022. Front Immunol. 13:838328. PubMed
  318. Sureshchandra S, et al. 2022. Cell Rep. 39:110938. PubMed
  319. Ndeupen S, et al. 2021. iScience. 24:103479. PubMed
  320. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  321. Gadi D, et al. 2022. Leukemia. 36:723. PubMed
  322. Studniberg SI, et al. 2022. Mol Syst Biol. 18:e10824. PubMed
  323. Huang Y, et al. 2022. iScience. 25:105209. PubMed
  324. Quintanal-Villalonga A, et al. 2022. STAR Protoc. 3:101776. PubMed
  325. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  326. Wang C, et al. 2015. Clin Immunol. 159: 47-57. PubMed
  327. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  328. Cruz J, et al. 2011. J Immunol. 186:2282. PubMed
  329. Reustle A, et al. 2022. Clin Transl Med. 12:e883. PubMed
  330. Bahcecioglu G, et al. 2021. Adv Sci (Weinh). 8:e2100128. PubMed
  331. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  332. Anadon CM, et al. 2022. STAR Protoc. 3:101649. PubMed
  333. Nadeu F, et al. 2022. Nat Med. 28:1662. PubMed
  334. Hirschberger S, et al. 2022. Front Med (Lausanne). 9:923502. PubMed
  335. Pathania AS, et al. 2022. Mol Ther Oncolytics. 25:308. PubMed
  336. Wang J, et al. 2022. iScience. 25:103971. PubMed
  337. Wu Y, et al. 2022. J Cancer Res Clin Oncol. . PubMed
  338. Woolley CR, et al. 2022. Immunohorizons. 6:47. PubMed
  339. Wendisch D, et al. 2021. Cell. 184:6243. PubMed
  340. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  341. Poon MML, et al. 2021. Cell Rep. 37:110071. PubMed
  342. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  343. Wegner J, et al. 2021. Sci Rep. 11:14983. PubMed
  344. Sun L, et al. 2021. Sci Rep. 11:12477. PubMed
  345. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  346. OConnor RA, et al. 2021. OncoImmunology. 10(1):1940675. PubMed
  347. Cheng Y, et al. 2021. Immunity. 54(8):1825-1840.e7. PubMed
  348. Glassman CR, et al. 2021. Cell. 184(4):983-999.e24. PubMed
  349. Zeng J, et al. 2020. Nat Med. 26:535. PubMed
  350. Qin XH, et al. 2019. Langmuir. 35:1882. PubMed
  351. Song M, et al. 2018. Nature. 562:423. PubMed
  352. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  353. Xue J, et al. 2020. Arthritis Res Ther. 1.070138889. PubMed
  354. Tsuboki J, et al. 2016. Sci Rep. 6:29588. PubMed
  355. Gao M, et al. 2016. Sci Rep. 6:29955. PubMed
  356. Stephanie Elizabeth, Johanna Zandee 2017. Immunol Cell Biol. 10.1038/icb.2017.3. PubMed
  357. Morales Pantoja IE, et al. 2020. PLoS One. 15:e0233980. PubMed
  358. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  359. Still C 2nd, et al. 2021. Cell Reports Medicine. 2(7):100343. PubMed
  360. Feng W, et al. 2020. J Vis Exp. . PubMed
  361. Hannon E, et al. 2021. PLoS Genet. e1009443:17. PubMed
  362. Li YR, et al. 2021. Cell Rep Med. 2:100449. PubMed
  363. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  364. Kusi M, et al. 2022. Cell Rep. 38:110220. PubMed
  365. Dahal S, et al. 2022. Retrovirology. 19:18. PubMed
  366. Cortés-López M, et al. 2022. Nat Commun. 13:5570. PubMed
  367. LaSalle TJ, et al. 2022. Cell Rep Med. 3:100779. PubMed
  368. Surendran N, et al. 2016. Innate Immunity. 22: 63 - 71. PubMed
  369. Lines J, et al. 2014. Cancer Res. 74:1924. PubMed
  370. Alves V, et al. 2013. Infect Immun . 81:4399. PubMed
  371. Ellyard JI, et al. 2019. Front Immunol. 1.898611111. PubMed
  372. Fan C, et al. 2019. Mol Med Rep. 3.002083333. PubMed
  373. Franco LM, et al. 2019. J Exp Med. 216:384. PubMed
  374. Oetjen KA, et al. 2018. JCI Insight. 3:e124928. PubMed
  375. Jiang X, et al. 2018. Cell Mol Immunol. 1.338194444. PubMed
  376. Gov L,et al. 2017. J Immunol. 10.4049/jimmunol.1700245. PubMed
  377. Metcalf T, et al. 2017. J Immunol. 10.4049/jimmunol.1700148. PubMed
  378. Huang D, et al. 2022. Cell Discov. 8:121. PubMed
  379. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  380. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  381. Lo YC, et al. 2022. Nat Commun. 13:934. PubMed
  382. Thakkar D, et al. 2022. J Immunother Cancer. 10:. PubMed
  383. Erickson JR, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  384. Wang X, et al. 2022. J Immunol. 208:396. PubMed
  385. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  386. Paul S, et al. 2021. Sci Transl Med. 13:. PubMed
  387. Combes AJ, et al. 2021. Nature. 591:124. PubMed
  388. Larson-Casey JL, et al. 2020. PLoS One. 15:e0241323. PubMed
  389. Carmona-Rivera C, et al. 2020. JCI Insight. 5:00. PubMed
  390. Guo JJ, et al. 2017. Exp Ther Med. 3.842361111. PubMed
  391. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  392. Nobre LV, et al. 2020. eLife. 8:e49894.. PubMed
  393. Szerlip N, et al. 2012. Proc Natl Acad Sci U S A. 109:3041. PubMed
  394. Bromley S, et al. 2013. J Immunol. 190:970. PubMed
  395. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  396. Page K, et al. 2015. J Pharmacol Exp Ther. 355: 199 - 205. PubMed
  397. Wanke-Jellinek L, et al. 2016. J Immunol. 196: 767 - 777. PubMed
  398. Schneeberger V, et al. 2016. PLoS One. 11: 0160587. PubMed
  399. Maini A, et al. 2016. PLoS One. 11:e0165502. PubMed
  400. Burel J, et al. 2016. PLoS Negl Trop Dis. 10:e0005031. PubMed
  401. Kirabo A, et al. 2017. J Mol Cell Cardiol. 10.1016/j.yjmcc.2017.03.001. PubMed
  402. Judge SJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  403. Greenlee JD, et al. 2021. eLife. 0.416666666666667. PubMed
  404. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  405. Hepprich M, et al. 2020. Cell Metab. 699:31. PubMed
  406. Demaree B, et al. 2021. Nat Commun. 1583:12. PubMed
  407. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  408. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  409. Hirschberger S, et al. 2021. EMBO Mol Med. 13:e14323. PubMed
  410. Liao M, et al. 2021. Aging (Albany NY). 13:22412. PubMed
  411. Gutierrez C, et al. 2021. Nat Cancer. 2:758. PubMed
  412. Georg P, et al. 2022. Cell. 185:493. PubMed
  413. Céspedes PF, et al. 2022. Nat Commun. 13:3460. PubMed
  414. Zhang F, et al. 2021. Genome Med. 13:64. PubMed
  415. Luque-Martin R, et al. 2021. J Immunol. 207:555. PubMed
  416. Li F, et al. 2022. Nat Commun. 13:4334. PubMed
  417. Rydyznski Moderbacher C, et al. 2022. J Clin Invest. :. PubMed
  418. Hwang B, et al. 2021. Nat Methods. 18:903. PubMed
  419. Montel-Hagen A, et al. 2022. Curr Protoc. 2:e403. PubMed
  420. López-Sanz C, et al. 2022. STAR Protoc. 3:101755. PubMed
  421. Nahid M, et al. 2016. J Leukoc Biol. 100: 339 - 349. PubMed
  422. Eichten A, et al. 2016. Cancer Res . 76: 2327-2339. PubMed
  423. Wierzbinska JA, et al. 2020. Genome Med. 12:29. PubMed
  424. Bricio–Moreno L, et al. 2018. Nat Commun. 2.204861111. PubMed
  425. Arrigucci R, et al. 2017. Nat Protoc. 1.364583333. PubMed
  426. Strazza M, et al. 2022. Mol Ther Methods Clin Dev. 27:380. PubMed
  427. Konkimalla A, et al. 2022. iScience. 25:105114. PubMed
  428. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  429. Liu Y, et al. 2022. Clin Transl Med. 12:e654. PubMed
  430. Ruan LY, et al. 2022. Biomolecules. 12:. PubMed
  431. Lederer K, et al. 2022. Cell. . PubMed
  432. Wang YM, et al. 2022. Oncoimmunology. 11:2034257. PubMed
  433. Jiang J, et al. 2021. Front Immunol. 12:785549. PubMed
  434. Yang Y, et al. 2021. Emerg Microbes Infect. 10:905. PubMed
  435. Shuwa HA, et al. 2021. Med. 2(6):720-735.e4. PubMed
  436. Landgraf KE, et al. 2020. Commun Biol. 0.330555556. PubMed
  437. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  438. Kubala MH, et al. 2018. Cell Rep. 25:2177. PubMed
  439. Wu X, et al. 2020. Front Immunol. 1.922222222. PubMed
  440. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  441. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  442. Wilkinson-Ryan I, et al. 2015. PLoS One. 10:125851. PubMed
  443. Ali A, et al. 2015. PLoS One. 10: 0131645. PubMed
  444. Kanzaki H, et al. 2016. Sci Rep. 6:32259. PubMed
  445. Goehring K, et al. 2016. J Nutr. 146(12):2559-2566. PubMed
  446. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  447. Maehara T, et al. 2020. J Clin Invest. 130:2451. PubMed
  448. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  449. Szodoray P, et al. 2021. Cell Reports. 36(6):109525. PubMed
  450. Jin HS, et al. 2020. Cancer Immunol Res. 8:912. PubMed
  451. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  452. Rovira-Clavé X, et al. 2021. Nat Commun. 12:4628. PubMed
  453. Wurm M, et al. 2021. Mol Cancer Ther. 20:2250. PubMed
  454. Pauken CM, et al. 2021. Cancers (Basel). 13:. PubMed
  455. Genge PC, et al. 2021. STAR Protoc. 2:100900. PubMed
  456. Winkler C, et al. 2021. JCI Insight. 6:. PubMed
  457. Adamo S, et al. 2022. Nature. 602:148. PubMed
  458. Krijgsman D, et al. 2022. STAR Protoc. 3:101034. PubMed
  459. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  460. Konishi S, et al. 2022. STAR Protoc. 3:101447. PubMed
  461. Galván-Peña S, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  462. Wilson TL, et al. 2022. Cancer Discov. 12:2098. PubMed
  463. Claireaux MAF, et al. 2022. Nat Commun. 13:4539. PubMed
  464. Allard-Chamard H, et al. 2021. J Immunol. 206:524. PubMed
  465. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  466. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  467. Delgado-Gonzalez A, et al. 2022. STAR Protoc. 3:101425. PubMed
  468. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  469. Nielsen S, et al. 2016. Nat Cell Biol. 18: 549-560. PubMed
  470. Jarantow S, et al. 2015. J Biol Chem. 290: 24689 - 24704. PubMed
  471. Anderson M, et al. 2014. Otolaryngology Head Neck Surg. 150:880. PubMed
  472. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  473. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  474. Cai Q, et al. 2019. Oncol Lett. 2.967361111. PubMed
  475. Yang ZZ, et al. 2019. Cell Rep. 26:2178. PubMed
  476. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  477. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  478. Alhussan A, et al. 2022. Cancers (Basel). 14:. PubMed
  479. Lee PC, et al. 2022. J Clin Invest. 132:. PubMed
  480. Rouhani SJ, et al. 2022. J Immunother Cancer. 10:. PubMed
  481. Chan M, et al. 2021. Mol Syst Biol. 17:e10426. PubMed
  482. Rodríguez-Lorenzo S, et al. 2022. Elife. 11:. PubMed
  483. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  484. Manríquez V, et al. 2021. Nat Commun. 12:4547. PubMed
  485. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  486. Salahudeen AA, et al. 2020. bioRxiv. . PubMed
  487. Qi J, et al. 2021. Cell Reports Medicine. 2(8):100353. PubMed
  488. Hara T, et al. 2021. Cancer Cell. 39(6):779-792.e11. PubMed
  489. Clayton KL, et al. 2021. Cell Host Microbe. 29(3):435-447.e9. PubMed
  490. Lynskey N, et al. 2017. PLoS Pathog.. 10.1371/journal.ppat.1006493. PubMed
  491. Eitas T, et al. 2017. PLoS One. 10.1371/journal.pone.0184164. PubMed
  492. Verma SK, et al. 2018. J Biol Chem. 293:254. PubMed
  493. Pleguezuelos O, et al. 2015. Clin Vaccine Immunol. 22: 828 - 835. PubMed
  494. Alasoo K, et al. 2015. Sci Rep. 5: 12524. PubMed
  495. Burel J, et al. 2016. PLoS Pathog. 12: 1005839. PubMed
  496. MacBride M, et al. 2017. Mammalian Genome. 10.1007/s00335-017-9680-0. PubMed
  497. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  498. Nistler R, et al. 2020. Immunohorizons. 0.397222222. PubMed
  499. Pettmann J, et al. 2021. eLife. 10:00. PubMed
  500. Luoma AM, et al. 2020. Cell. 182(3):655-671.e22. PubMed
  501. Perugino CA, et al. 2021. J Allergy Clin Immunol. 368:147. PubMed
  502. Shaw BC, et al. 2021. CRISPR J. 4:699. PubMed
  503. Chen C, et al. 2022. iScience. 25:103645. PubMed
  504. Lu J, et al. 2022. STAR Protoc. 3:101559. PubMed
  505. Ainsworth RI, et al. 2022. Nat Commun. 13:6221. PubMed
  506. An L, et al. 2016. Sci Rep. 6: 33346. PubMed
  507. Wolf J, et al. 2016. J Biol Chem. 291: 16186 - 16196. PubMed
  508. Schneck H, et al. 2015. PLoS One. 10: 0144535. PubMed
  509. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  510. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  511. Itoh H, et al. 2017. J Vet Med. 10.1155/2017/5701016. PubMed
  512. Kamada R, et al. 2017. The Journal of Biochemistry. 10.1093/jb/mvx032. PubMed
  513. Yao W, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.017. PubMed
  514. Jeong HO, et al. 2022. iScience. 25:105358. PubMed
  515. Murphy DM, et al. 2022. J Clin Invest. Online ahead of print. PubMed
  516. Faissner S, et al. 2022. Front Immunol. 13:980526. PubMed
  517. Zha Y, et al. 2022. Front Immunol. 13:877314. PubMed
  518. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  519. Medeiros-Furquim T, et al. 2022. Front Immunol. 13:678817. PubMed
  520. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
  521. Kämpe A, et al. 2021. PLoS One. 16:e0257442. PubMed
  522. Pinto SM, et al. 2021. Front Immunol. 12:679458. PubMed
  523. Chiou SH, et al. 2021. Immunity. 54:586. PubMed
  524. Wang EY, et al. 2021. Nature. 595:283. PubMed
  525. Mpakou V, et al. 2021. Exp Ther Med. 1.010416667. PubMed
  526. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  527. Sainson RCA, et al. 2020. Cancer Immunol Res. 1.422222222. PubMed
  528. Salahudeen AA, et al. 2020. Nature. 588:670. PubMed
  529. Okamura Y, et al. 2017. Allergol Int. 10.1016/j.alit.2017.03.002. PubMed
RRID
AB_2818986 (BioLegend Cat. No. 422302)

Antigen Details

Molecular Family
Fc Receptors
Gene ID
NA

Related FAQs

Is our human Trustain FcX™ (cat# 422302) compatible with anti human CD16, CD32 and CD64 clones 3G8, FUN-2 and 10.1 respectively?

Yes

What is the concentration of Human TruStain FcX™ (Fc receptor blocking solution, Cat#422301)?
This information is proprietary.
Go To Top Version: 4    Revision Date: 07/14/2016

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account